Umesh Muchhal
26Patents
7h-index
29Co-inventors
69Inventor score
Filing activity: May 6, 2002 → Apr 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9856327B2 | Heterodimeric antibodies to CD3 X CD123 | Chemistry; Metallurgy | 64 | Active |
| US7244823B2 | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders | Chemistry; Metallurgy | 29 | Expired |
| US10526417B2 | Heterodimeric antibodies that bind CD3 and CD38 | Chemistry; Metallurgy | 25 | Active |
| US9850320B2 | Heterodimeric antibodies to CD3 X CD20 | Chemistry; Metallurgy | 11 | Active |
| US7144987B1 | Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders | Chemistry; Metallurgy | 11 | Expired |
| US10259887B2 | Heterodimeric antibodies that bind CD3 and tumor antigens | Chemistry; Metallurgy | 7 | Active |
| US11225528B2 | Heterodimeric antibodies that bind CD3 and tumor antigens | Chemistry; Metallurgy | 7 | Active |
| US11472890B2 | Heterodimeric antibodies that bind ENPP3 and CD3 | Chemistry; Metallurgy | 5 | Active |
| US8394374B2 | Optimized antibodies that target HM1.24 | Chemistry; Metallurgy | 4 | Active |
| US7071307B2 | Nucleic acids and proteins with thioredoxin reductase activity | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9701743B2 | Complement component C5 antibodies | Chemistry; Metallurgy | 2 | Active |
| US11312770B2 | Bispecific and monospecific antibodies using novel anti-PD-1 sequences | Chemistry; Metallurgy | 1 | Active |
| US11352442B2 | Heterodimeric antibodies that bind CD3 and CD38 | Chemistry; Metallurgy | 1 | Active |
| US9932395B2 | Nucleic acids encoding complement component C5 antibodies | Chemistry; Metallurgy | 1 | Active |
| US11859011B2 | Heterodimeric antibodies that bind CD3 and tumor antigens | Chemistry; Metallurgy | 0 | Active |
| US11673972B2 | Heterodimeric antibodies that bind CD3 and tumor antigens | Chemistry; Metallurgy | 0 | Active |
| US11111315B2 | Heterodimeric antibodies that bind CD3 and tumor antigens | Chemistry; Metallurgy | 0 | Active |
| US12152076B2 | Bispecific and monospecific antibodies using novel anti-PD-1 sequences | Chemistry; Metallurgy | 0 | Active |
| US12359002B2 | Heterodimeric antibodies that bind CD3 and tumor antigens | Chemistry; Metallurgy | 0 | Active |
| US10752678B2 | Complement component C5 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11492407B2 | Bispecific checkpoint inhibitor antibodies | Chemistry; Metallurgy | 0 | Active |
| US10913803B2 | Heterodimeric antibodies that bind CD3 and tumor antigens | Chemistry; Metallurgy | 0 | Active |
| US12129309B2 | Heterodimeric antibodies that bind CD3 and CD38 | Chemistry; Metallurgy | 0 | Active |
| US10889653B2 | Heterodimeric antibodies that bind CD3 and tumor antigens | Chemistry; Metallurgy | 0 | Active |
| US11945880B2 | Heterodimeric antibodies that bind CD3 and tumor antigens | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.